首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

市場調查報告書

商品編碼

1643896

全球輸液幫浦市場 - 2025-2033

Global Infusion Pumps Market - 2025-2033

出版日期: 2025年01月27日 | 出版商:

DataM Intelligence | 英文 236 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球輸液幫浦市場規模達164億美元，預計2033年將達265億美元，2025-2033年預測期間複合年成長率為4.2%。

輸液幫浦是一種醫療設備，它以受控的方式向患者輸送液體。基本上有許多不同類型的輸液幫浦用於多種不同的目的和環境。輸液幫浦可以具有非常廣泛的輸送設置，從大容量到低至微量輸送，並且通常用於 TPN 應用和各種類型的 IV 藥物 - 胰島素和激素、化療藥物、抗生素、鎮痛藥等一些輸液泵可在床邊使用；其他設計為攜帶式輸液泵，以提高便攜性或耐磨性。

市場動態：

驅動程式和限制

科技進步的快速成長

目前，快速發展的技術進步正在全球輸液幫浦市場的變革中發揮重要作用。具有無線連接的智慧輸液幫浦和藥物庫等進步和創新為藥物傳遞的可靠性和安全性做出了巨大貢獻。這些解決方案還整合了即時監控、錯誤減少系統和遠端程式設計等高科技功能，正在解決重症監護病房等高風險環境中病患照護的關鍵問題。

例如，2024年1月，全球首次開發出具有安全檢測給藥技術的輸液幫浦。由資深研究員 Dong-kyu Lee 領導的韓國機械與材料研究所開發了客製化感測器模組，用於測量鎮痛藥物輸注幫浦的低流量和氣泡的存在。該安全泵系統正在由韓國著名的藥物注射器製造商 Unimedics 開發並用於大量生產。該技術旨在防止因過量服用鎮痛藥物而引發的醫療事故。

產品召回

全球輸液幫浦的市場成長受到產品召回的阻礙。事實上，大多數召回都是由製造缺陷、軟體故障或導致患者不良暴露的安全問題引發的。這會導致品牌聲譽受損，並可能導致市場成長短暫停滯。召回引發了監管機構更嚴格的審查，並花費數十億美元重新設計成合規產品，這直接影響製造商的獲利能力。

例如，2024 年 10 月，Zyno Medical 召回了部分 Z800 輸液泵，因為管線內空氣軟體演算法有缺陷，可能會導致 1 mL 氣泡進入患者體內。該產品可能會導致嚴重的不良健康後果，包括血管空氣栓塞、快速心律不整、心肌梗塞、中風、癲癇發作和死亡。據報道有兩人受傷。

同樣，2024 年 4 月，InfuTronix, LLC 因電池故障、上游堵塞、系統錯誤、藥品洩漏、流速高或低或外殼損壞等潛在故障模式而召回 Nimbus 輸液泵系統，自 2024 年 6 月 20 日起生效。

Baxter International Inc
B. Braun Melsungen AG
Fresenius Kabi AG
ICU Medical, Inc
Terumo Corporation
Micrel Medical Devices SA
Moog Inc
Mindray Medical International Ltd
BD (Becton, Dickinson and Company)
Similar data will be provided for each market player.
科魯醫療系統
- 管道產品說明
- 產品關鍵績效指標 (KPI)
- 主要活動
- 市場進入時間表
- 產品滲透率
- 銷售估算與預測
Tandem 糖尿病護理公司
伊坦醫療
Q-Core醫療有限公司
將為每個市場參與者提供類似的資料。

第 12 章：附錄

簡介目錄

Product Code: MD2889

The global infusion pumps market reached US$ 16.4 billion in 2024 and is expected to reach US$ 26.5 billion by 2033, growing at a CAGR of 4.2% during the forecast period 2025-2033.

Infusion pumps are the medical devices that's delivers a patient to flow fluids externally and in a controlled format. There are basically many different types of infusion pumps which serve several different purposes and environments. An infusion pump can have a very wide range of delivery settings from large volume down to as low as micro delivery, and often are used in both TPN applications and various types of I.V. medications - insulin and hormones, chemotherapeutic agents, antibiotics, analgesics, etc. Some infusion pumps present themselves for use at the bedside; others are designed as ambulatory infusion pumps for portability or wearability.

Market Dynamics: Drivers & Restraints

Rapid Increase of Technological Advancements

At present, fast-growing technological advancement is taking an essential part in transforming the infusion pumps market worldwide. The advancements and innovations such as smart infusion pumps with wireless connections and drug libraries have contributed a lot toward drug delivery in terms of reliability and safety. Also integrated with high-tech features such as real-time monitoring, error reduction systems, and remote programming, these solutions are addressing critical issues about patient care in high-risk settings such as intensive care units.

For instance, in January 2024, a drug infusion pump with a technology for safely detecting medication administration has been developed for the first time globally. The Korea Institute of Machinery and Materials, led by Senior Researcher Dong-kyu Lee, developed customized sensor modules to measure the low flow rate of analgesic drug infusion pumps and the presence of bubbles. The safe pump system is being developed for mass production by Unimedics, a renowned manufacturer of medication injectors in Korea. This technology aims to prevent medical accidents caused by excessive analgesic drug administration.

Product Recalls

The market growth of global infusion pumps are hindered by product recalls. In fact, most recalls are triggered by manufacturing faults, software malfunctioning, or safety issues that lead to adverse patient exposure. This results into tarnishing brand names and is capable of causing a very transient stall in market growth. Recalls provoke greater scrutiny from regulators and cost Billions of dollars to be re-engineered into compliant products which directly affect the profitability of manufacturers.

For instance, in October 2024, Zyno Medical is recalled select Z800 infusion pumps due to a defect in the air-in-line software algorithm, potentially allowing a 1 mL air bubble to pass to a patient. The product may cause serious adverse health consequences, including vascular air embolism, tachyarrhythmia, myocardial infarction, stroke, seizure, and death. There have been two reported injuries.

Similarly, in April 2024, InfuTronix, LLC is recalled Nimbus infusion pump systems due to potential failure modes such as battery failure, upstream blockage, system errors, drug product leakage, high or low flow rate, or damaged housing, effective June 20, 2024.

Segment Analysis

The global infusion pumps market is segmented based on product type, technology, application, end user and region.

Product Type:

Syringe infusion pumps segment is expected to dominate the Infusion Pumps market share

The syringe infusion pumps segment holds a major portion of the infusion pumps market share and is expected to continue to hold a significant portion of the infusion pumps market share during the forecast period.

Syringe infusion pumps are a vital component of the global infusion pumps market, providing precise and controlled delivery of small volumes of fluids and medications. They are particularly useful in critical care settings like neonatal and pediatric care, where accuracy is crucial due to patients' small size and sensitivity to dosage errors. They are also crucial for administering high-potency drugs like chemotherapy agents, anesthetics, and pain management medications. Their compact design and ability to deliver medications at low flow rates make them ideal for hospital and ambulatory care. Advancements in syringe pump technology, such as dose error reduction systems and wireless connectivity, have enhanced their efficiency and safety.

For instance, in April 2024, Baxter International has received FDA 510(k) clearance for its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. This addition to the Novum IQ Infusion Platform, which includes Baxter's syringe infusion pump (SYR) with Dose IQ Safety Software, allows clinicians to use a single, integrated system across various patient care settings. Baxter's commitment to innovation in infusion therapy is demonstrated by offering the Novum IQ LVP in the U.S.

End User:-

Hospitals segment is the fastest-growing segment in Infusion Pumps market share

The hospitals segment is the fastest-growing segment in the infusion pumps market share and is expected to hold the market share over the forecast period.

Hospitals are the largest end-users of infusion pumps globally, providing precise and controlled dosages of fluids, medications, and nutrients to patients across various departments. The increasing incidence of chronic diseases, surgical procedures, and critical care requirements has increased demand for infusion pumps.

For instance, in April 2024, Mackenzie Health has introduced BD Alaris EMR Interoperability, a two-way information flow technology that enables two-way communication between an IV medication pump and a patient's electronic medical record. This eliminates the need for healthcare professionals to manually program pumps and send infusion safety information back to Epic EMR, thereby reducing administration errors and providing accurate infusion records.

Moreover, in April 2023, Nathan Littauer Hospital & Nursing Home has opted for B Braun Medical Inc.'s Infusomat Space 2nd Generation Large Volume Pumps due to their efficiency and accuracy, ensuring safer patient care for the hospital's patients.

Geographical Analysis

North America is expected to hold a significant position in the Infusion Pumps market share

North America holds a substantial position in the infusion pumps market and is expected to hold most of the market share due to its advanced healthcare infrastructure, FDA approvals, high healthcare expenditure, and early adoption of innovative medical technologies. The region's high prevalence of chronic diseases like diabetes, cancer, and cardiovascular disorders drives demand for infusion pumps. Major market players like Medtronic, Baxter, and B. Braun ensure continuous innovation and availability of cutting-edge products. The strong regulatory framework and emphasis on patient safety drive the adoption of smart infusion pumps with integrated error-reduction systems.

For instance, in May 2024, Moog Inc has secured 510(k) clearance from the United States Food and Drug Administration (FDA) for the CURLIN 8000 Ambulatory Infusion System in the Industrial segment. This high-end infusion platform has been designed specifically for use in home infusion facilities.

Moreover, in July 2023, Becton, Dickinson and Company, or BD, is a global leader in medical technology that announced that the BD Alaris update, the latest version of the BD Alaris Infusion System, has been granted 510(k) clearance by the United States Food and Drug Administration (FDA) to remediate and then return to full commercial operations for the most comprehensive use-infusion system in the United States.

Europe is growing at the fastest pace in the Infusion Pumps market

Europe holds the fastest pace in the infusion pumps market and is expected to hold most of the market share due to aging population and chronic diseases. Countries like Germany, France, and the UK lead the market due to their advanced healthcare systems. The focus on personalized medicine and homecare has increased demand for portable infusion pumps. The European Union's focus on reducing hospital stays and promoting outpatient care has fueled the adoption of infusion technology in ambulatory settings. Government funding, collaborations, and competitive pricing from local and international manufacturers drive market growth.

For instance, in May 2023, Fresenius Kabi announced that it has joined Premier, Inc. in a Breakthrough Technology group purchasing agreement. Under the agreement, which comes into effect May 1, 2023, Premier members may opt to take advantage of special pricing and terms negotiated in advance by Premier for the Ivenix Infusion System from Fresenius Kabi.

Competitive Landscape

The major global players in the infusion pumps market include Medtronic plc, Baxter International Inc, B. Braun Melsungen AG, Fresenius Kabi AG, ICU Medical, Inc, Terumo Corporation, Micrel Medical Devices SA, Moog Inc, Mindray Medical International, Ltd, BD (Becton, Dickinson and Company) and among others.

Key Developments

In June 2023, B. Braun Medical Inc. has launched DoseTrac Enterprise Infusion Management Software, a next-generation infusion management software. The software offers real-time views and retrospective reporting features to help organizations understand their infusion pump fleet and associated data. It can connect up to 40,000 pumps at an unlimited number of facilities with just one application.
In February 2023, Mindray has introduced its BeneFusion i Series and u Series infusion systems, offering high precision, adaptive customization, and simplicity for medication safety in various clinical settings, available in select countries and regions.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global infusion pumps market report delivers a detailed analysis with 68+ key tables, more than 72 visually impactful figures, and 236 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rapid Increase of Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Product Recalls
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Syringe Infusion Pumps*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Volumetric Infusion Pumps
6.4. Ambulatory Infusion Pumps
6.5. Insulin Infusion Pumps
6.6. Patient-Controlled Analgesia (PCA) Pumps
6.7. Elastomeric Pumps
6.8. Implantable Infusion Pumps
6.9. Enteral Infusion Pumps

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Traditional Pumps*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Smart Pumps
7.4. Wearable Pumps

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Oncology*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Diabetes Management
8.4. Gastroenterology
8.5. Pediatrics/Neonatology
8.6. Analgesia/Pain Management
8.7. Cardiology
8.8. Critical Care/ICU
8.9. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers (ASCs)
9.4. Homecare Settings
9.5. Specialty Clinics

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

12.1. Medtronic Plc*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio
  - 12.1.2.1. Product Description
  - 12.1.2.2. Product Key Performance Indicators (KPIs)
  - 12.1.2.3. Historic and Forecasted Product Sales
  - 12.1.2.4. Product Sales Volume
- 12.1.3. Financial Overview
  - 12.1.3.1. Company Revenue's
  - 12.1.3.2. Geographical Revenue Shares
  - 12.1.3.3. Revenue Forecasts
- 12.1.4. Key Developments
  - 12.1.4.1. Mergers & Acquisitions
  - 12.1.4.2. Key Product Development Activities
  - 12.1.4.3. Regulatory Approvals etc.
- 12.1.5. SWOT Analysis
12.2. Baxter International Inc
12.3. B. Braun Melsungen AG
12.4. Fresenius Kabi AG
12.5. ICU Medical, Inc
12.6. Terumo Corporation
12.7. Micrel Medical Devices SA
12.8. Moog Inc
12.9. Mindray Medical International Ltd
12.10. BD (Becton, Dickinson and Company)
Similar data will be provided for each market player.

Emerging Market Players

12.11. KORU Medical Systems*
- 12.11.1. Pipeline Products Description
- 12.11.2. Product Key Performance Indicators (KPIs)
- 12.11.3. Key Activities
- 12.11.4. Market Entry Timelines
- 12.11.5. Product Penetration Rate
- 12.11.6. Sales Estimation and Projections
12.12. Tandem Diabetes Care, Inc
12.13. Eitan Medical
12.14. Q-Core Medical Ltd
Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE